about
Thrombotic thrombocytopenic purpura is associated with a high relapse rate after plasma exchange: a single-centre experience.Thrombocytopenia and erythrocytosis in mice with a mutation in the gene encoding the hemoglobin β minor chain.Characterization of thrombopoietin (TPO)-responsive progenitor cells in adult mouse bone marrow with in vivo megakaryocyte and erythroid potentialGFI1B mutation causes a bleeding disorder with abnormal platelet function.BCL-2 is dispensable for thrombopoiesis and platelet survivalMultipotential hematopoietic blast colony-forming cells exhibit delays in self-generation and lineage commitment.Early lineage priming by trisomy of Erg leads to myeloproliferation in a Down syndrome model.Use of a Therapeutic, Socially Assistive Pet Robot (PARO) in Improving Mood and Stimulating Social Interaction and Communication for People With Dementia: Study Protocol for a Randomized Controlled Trial.Transposon mutagenesis reveals cooperation of ETS family transcription factors with signaling pathways in erythro-megakaryocytic leukemiaHaematopoietic stem cells: past, present and future.Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation.Haemopedia: An Expression Atlas of Murine Hematopoietic Cells.Murine hematopoietic blast colony-forming cells and their progeny have distinctive membrane marker profiles.Resolution of platelet function defects with imatinib therapy in a patient with chronic myeloid leukaemia in chronic phase.Thrombocytopenia and CD34 expression is decoupled from α-granule deficiency with mutation of the first growth factor-independent 1B zinc finger.Professor Donald Metcalf (1929–2014).Altered B-lymphopoiesis in mice with deregulated thrombopoietin signaling.Epilepsy, progessive movement disorder and cognitive decline.Erg is required for self-renewal of hematopoietic stem cells during stress hematopoiesis in mice.Early therapeutic response assessment by (18)FDG-positron emission tomography during chemotherapy in patients with diffuse large B-cell lymphoma: isolated residual positivity involving bone is not usually a predictor of subsequent treatment failure.JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemiasHhex induces promyelocyte self-renewal and cooperates with growth factor independence to cause myeloid leukemia in miceHaemopedia RNA-seq: a database of gene expression during haematopoiesis in mice and humansImpact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in miceScreening with spirometry is a useful predictor of later development of noninfectious pulmonary syndromes in patients undergoing allogeneic stem cell transplantationmiR17~92 restrains pro-apoptotic BIM to ensure survival of haematopoietic stem and progenitor cellsRIPK1 prevents TRADD-driven, but TNFR1 independent, apoptosis during developmentDevelopment and survival of MYC-driven lymphomas require the MYC antagonist MNT to curb MYC-induced apoptosisI myelofibrosis! Veni VitD! Et tu, macrophage?Targeting platelets for improved outcome in KRAS-driven lung adenocarcinomaAn Erg-driven transcriptional program controls B cell lymphopoiesis
P50
Q33379313-BF46AEA2-B845-4C77-87E4-E0E3446B89AEQ33398945-1E5163BF-405F-48B9-A21F-46507E7FA3A9Q33399510-481E93B0-78F1-40A1-B770-C95A1748CDCCQ33409618-614117DF-84B6-4A89-A585-577F8B9F2E44Q33422077-00009B61-D541-4BC3-AE62-6AC1030C181EQ34136512-A0D99C69-106A-45A6-AC71-BAECC903AA35Q35606539-D8A3B215-2192-4DE4-8572-279AFA83E0DFQ35611783-F01854CD-4EF5-4007-8791-DD61F0C531BBQ36762524-6980CB12-DD98-45B1-BA81-B5F06FA82292Q37625810-001181B9-C684-409E-B249-144A8E22B68EQ37725327-9EE188CD-42B9-4B9C-8AA4-D6C34310CD88Q39515020-A0880C1A-2C7B-47FB-A578-50159A88BC0DQ42633260-4F4C552B-C750-49AF-8099-70B73CC47195Q43044744-67AC9E9F-AC06-4148-AB5C-48968304848FQ47816472-E2673AB1-C8A0-42D8-9A13-5D27D2815859Q48046497-BA523CBD-3AE5-4232-9A1E-630ED9C870BCQ48372668-8C37448F-C061-494B-90F3-866AD9026642Q51888998-3C212D8D-6F33-440A-9F16-734EEF6271D1Q53240659-E314C5E8-6F97-4F18-B96D-6449D7831EBCQ53485736-E3962EB1-5028-45BF-BA05-924A1E47148DQ57272422-F87A6BCE-2780-4048-A1F3-8DDB492E3770Q58377838-48F1F98E-D31D-43C0-A598-A7966726E820Q58611636-2CFCB15D-F9F7-4768-930A-2685EA32EA37Q60274110-C5E378A3-E597-4361-AB78-E65D7F850958Q87318460-899F5566-4A2E-46B6-84D6-29F9C2C9888CQ90575572-5CEC4120-BD1A-487E-AFA9-9E5524CBA5DEQ91304398-17624E87-0A1D-47C6-AE44-884305C1CA1DQ92915896-792F9C27-D591-4A43-A0F2-7E6CD6273F3EQ93038532-326BFEFD-B347-4287-8D70-933764A99221Q96340455-F2B4394D-7485-4447-8D92-F6961C3CAA71Q96430927-AAB656FC-4C99-4640-A391-3431CC6D3228
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ashley P Ng
@ast
Ashley P Ng
@en
Ashley P Ng
@es
Ashley P Ng
@nl
type
label
Ashley P Ng
@ast
Ashley P Ng
@en
Ashley P Ng
@es
Ashley P Ng
@nl
prefLabel
Ashley P Ng
@ast
Ashley P Ng
@en
Ashley P Ng
@es
Ashley P Ng
@nl
P106
P1153
26321881900
P31
P496
0000-0001-9690-0879